Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04017702 · ClinicalTrials.gov registry record
Detection of Postoperative Respiratory Depression in High Risk Patients Utilizing Minute Ventilation Monitoring
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 86
- Enrollment target
NCT04017702: Completed study, sponsored by Yale University.
NCT04017702 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 86 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04017702 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
Study Summary
Respiratory volume monitor (RVM) (ExSpiron) is superior to continuous pulse oximetry in detection of postoperative respiratory depression in high risk patients.
Primary Outcome
To define the incidence of postoperative respiratory depression between 2 devices.
Interventions
- DEVICE Expiron respirator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2018-06-20 |
| Est. Completion | 2020-02-20 |
What the finished NCT04017702 record still lists
NCT04017702 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 86 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Expiron respirator is the first listed.
NCT04017702 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04017702 about?
NCT04017702 is a clinical study titled "Detection of Postoperative Respiratory Depression in High Risk Patients Utilizing Minute Ventilation Monitoring". Respiratory volume monitor (RVM) (ExSpiron) is superior to continuous pulse oximetry in detection of postoperative respiratory depression in high risk patients.
What is the current status of trial NCT04017702?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2018-06-20. Estimated completion is 2020-02-20.
What interventions are being tested in trial NCT04017702?
The interventions under investigation include: Expiron respirator (DEVICE).
Who is sponsoring clinical trial NCT04017702?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI